Literature DB >> 20962444

Fabry disease exhibiting recurrent stroke and persistent inflammation.

Yoko Kikumoto1, Yasufumi Kai, Hiroshi Morinaga, Mutsunori Iga-Murahashi, Mikitaro Matsuyama, Takashi Sasaki, Hiroki Maruyama, Masaaki Shimotori, Hirofumi Makino, Hitoshi Sugiyama, Akihiko Okayama.   

Abstract

We describe two cases of Fabry disease in non-blood-related Japanese men, manifesting recurrent stroke even after the start of enzyme replacement therapy. Both exhibited chronic inflammation and ocular involvement with elevated levels of serum C reactive protein prior to the onset of stroke. We, therefore, suggest the association among persistent inflammation, ocular involvement and recurrent stroke in a certain subset of Fabry disease patients. Both cases received enzyme replacement therapy with no improvement in inflammatory signs or laboratory data. These cases suggest that Fabry disease should be considered in young patients with cryptogenic stroke or CNS manifestations and fever of unknown origin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20962444     DOI: 10.2169/internalmedicine.49.3724

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  6 in total

Review 1.  Neurocutaneous Disorders for the Practicing Neurologist: a Focused Review.

Authors:  Anna Carolina Paiva Costa T Figueiredo; Nikolas Mata-Machado; Matthew McCoyd; José Biller
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

2.  Evidence for inflammation in Fabry's disease? Headache and muscle involvement responding to corticosteroid and methotrexate treatment.

Authors:  Markus Kraemer; N Karabul; P Berlit; A Rolfs
Journal:  J Neurol       Date:  2017-01-27       Impact factor: 4.849

Review 3.  Sphingolipids as Regulators of Neuro-Inflammation and NADPH Oxidase 2.

Authors:  Emma J Arsenault; Colin M McGill; Brian M Barth
Journal:  Neuromolecular Med       Date:  2021-02-05       Impact factor: 4.103

Review 4.  The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts.

Authors:  Dominique P Germain; Perry M Elliott; Bruno Falissard; Victor V Fomin; Max J Hilz; Ana Jovanovic; Ilkka Kantola; Aleš Linhart; Renzo Mignani; Mehdi Namdar; Albina Nowak; João-Paulo Oliveira; Maurizio Pieroni; Miguel Viana-Baptista; Christoph Wanner; Marco Spada
Journal:  Mol Genet Metab Rep       Date:  2019-02-06

5.  Urine bikunin as a marker of renal impairment in Fabry's disease.

Authors:  Antonio Junior Lepedda; Laura Fancellu; Elisabetta Zinellu; Pierina De Muro; Gabriele Nieddu; Giovanni Andrea Deiana; Piera Canu; Daniela Concolino; Simona Sestito; Marilena Formato; Gianpietro Sechi
Journal:  Biomed Res Int       Date:  2013-06-12       Impact factor: 3.411

6.  Recurrent fever of unknown origin: An overlooked symptom of Fabry disease.

Authors:  Yi Luo; Di Wu; Min Shen
Journal:  Mol Genet Genomic Med       Date:  2020-08-14       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.